Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

PHASE2RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 2, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Urticaria, IdiopathicHidradenitisHidradenitis Suppurativa
Interventions
DRUG

CSU lower dose treatment

CSU lower dose treatment

DRUG

CSU high dose treatment

CSU high dose treatment

DRUG

CSU non responders IgE - high dose treatment

CSU non responders IgE - high dose treatment

DRUG

HS low dose treatment

HS low dose treatment

DRUG

HS medium dose treatment

HS medium dose treatment

DRUG

HS high dose treatment

HS high dose treatment

Trial Locations (29)

1407

RECRUITING

ASMC IPSMC Skin and Venereal Diseases,, Sofia

RECRUITING

Medical Center Excelsior OOD,, Sofia

4200

RECRUITING

Medical Center Etika, Plovdiv

5500

RECRUITING

Medical Center Medconsult, Pleven OOD, Lovech

5800

RECRUITING

Medical Center Medconsult pleven OOD, Pleven

6010

RECRUITING

"LTD Health", Batumi

11415

RECRUITING

Forest Hills Dermatology Group, Kew Gardens

12203

RECRUITING

"Institut Allergieforschung Charité - Universitatsmedizin Berlin", Berlin

12462

RECRUITING

"General University Hospital Attikon", Athens

33162

RECRUITING

Ziaderm Research LLC, North Miami Beach

33613

RECRUITING

ForCare Clinical Research, Tampa

42071

RECRUITING

Kentucky Advanced Medical Research LLC, Murray

44791

RECRUITING

Katholisches Klinikum Bochum gGmbH/ St.Josef-Hospital Bochum, Dermatologie, Bochum

45324

RECRUITING

Wright State Physicians, Fairborn

46250

RECRUITING

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

56403

RECRUITING

"General Hospital of Thessaloniki Papageorgiou", Thessaloniki

60950

RECRUITING

Universitätsklinikum Frankfurt, Klinik für Dermatologie, Venerologie und Allergologie, Frankfurt

64506

RECRUITING

MediSearch LLC, Saint Joseph

78213

RECRUITING

Progressive Clinical Research, PA, Texas City

80337

RECRUITING

"Klinikum der Universitat (LMU) Klinik und Poliklinik far Dermatologie und Allergologie", München

92708

RECRUITING

First OC Dermatology Research Inc., Fountain Valley

0112

RECRUITING

"LTD Israel-Georgian Medical Research Clinic Healthycore", Tbilisi

0159

RECRUITING

"LLC Center of Allergy and Immunology", Tbilisi

0160

RECRUITING

"LLC Aversi Clinic", Tbilisi

01307

RECRUITING

Universitatsklinikum Dresden Carl Gustav Carus, Dresden

80-214

RECRUITING

Klinika Dermatologii, Wenerologii i Alergologii, UNIWERSYTECKIE CENTRUM KLINICZNE, ul., Gdansk

90-153

RECRUITING

Oddziat Kliniczny Wewnetrznych, Astmy i Alergii z Odcinkiem dla Dzieci, Samodzielny Publiczny Zaktad Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny, Lodz

42-624

RECRUITING

Labderm Essence sp., Ossy

50-566

RECRUITING

"Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spolka Partnerska", Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

InflaRx GmbH

INDUSTRY

NCT06555328 - Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa | Biotech Hunter | Biotech Hunter